Healthtech is advancing at a remarkable pace, but true impact happens when science, business, and patient needs align. With more than two decades at this intersection—beginning in chemistry and toxicology research and evolving into executive leadership—I’ve seen firsthand that the best leaders are translators. By turning complex discoveries into practical solutions, I’ve helped scale enterprises, launch new diagnostics, and guide innovation from the lab bench to the marketplace. The future of healthtech depends not just on discovery, but on disciplined leadership that bridges vision with execution, ensuring breakthroughs reach the patients who need them most.

I’m passionate about building digital health solutions that empower people to take control of their healthcare journeys. Over the past decade, I’ve led MEMOTEXT and co-founded A4i Inc., a joint venture with CAMH, to bring data-driven, personalized engagement tools to life—especially in mental health. With a background in information systems and a career spanning healthcare, real estate, and consulting, I’m driven by a simple philosophy: create smarter systems that integrate people, process, and technology to make a lasting impact.

Raymond Chang is a seasoned Translational Imaging Scientist with over two decades of experience spanning pharmaceutical research, contract research organizations, and academic discovery. Renowned for his expertise in advanced imaging modalities such as PET, SPECT, and CT, Chang has contributed significantly to the development of preclinical disease models and innovative therapeutics. His career highlights include leading the enterprise implementation of multimodality bioinformatics systems, developing cutting-edge imaging tools, and managing GLP and Non-GLP studies that bridge preclinical and clinical research. A dedicated leader and collaborator, Chang excels in regulatory compliance, experimental design, and fostering partnerships, making him a pivotal figure in advancing personalized medicine and imaging science.

I am excited to share my professional journey as a health economist and healthcare strategist with over 17 years of global experience. My work focuses on aligning economic evaluation with innovative healthcare technologies to create sustainable solutions for public and private payers. Here is my biography.

Technology is transforming cancer diagnosis and treatment, offering new opportunities to improve global health outcomes, particularly in underserved regions. Innovations such as telepathology, advanced imaging, and AI-based tools are bridging the gap between healthcare providers and specialized expertise, enhancing diagnostic accuracy and speeding up treatment processes. However, challenges like infrastructure limitations, cost, and data security need to be addressed for successful implementation. This article explores these technological advancements, their real-world applications, and offers key recommendations for healthcare leaders looking to adopt similar solutions in cancer care. #CancerCare #Telepathology #AIInHealthcare #AdvancedImaging #GlobalHealth #HealthcareInnovation

I’m excited to share a glimpse into my professional journey and achievements. With a Ph.D. in Immunology from the Hebrew University of Jerusalem and extensive experience at the National Institute of Allergy and Infectious Diseases (NIAID), I’ve had the privilege of leading transformative research in cancer immunotherapy and PET imaging of cancer biomarkers. My work has focused on advancing personalized medicine and targeted therapies, and I’m passionate about driving innovation in these fields. I invite you to explore my career highlights and contributions, which reflect my commitment to impactful research and visionary leadership. Thank you for your support and interest!